Clinical Trials on Metastatic Spinal Cord Compression in Belgium

Total 104 results

Thomas More Kempen
AZ Herentals

Recruiting

Robot Assisted Gait Training in Persons With a Spinal Cord Injury

SCI - Spinal Cord Injury

Belgium
Université Catholique de Louvain

Completed

Effect of Adaptive Sports After Acquired Physical Disability

Spinal Cord Injuries | Sports Physical Therapy

Belgium
Annemie Spooren
Universitaire Ziekenhuizen KU Leuven; University of Aarhus; University Hospital... and other collaborators

Not yet recruiting

Neural Plasticity and Motor Recovery After Early and Intensive Upper Extremity Motor Training in People With c-SCI (REPAIR-SCI)

Spinal Cord Injuries

Belgium, Netherlands
Hasselt University
Universitaire Ziekenhuizen KU Leuven; University Ghent; Adelante Zorggroep

Recruiting

Task-oriented Arm/Hand Skill Rehabilitation and Therapy Dose Dimensions in Subacute Spinal Cord Injury Rehabilitation

Spinal Cord Injuries

Belgium, Netherlands
Pharmazz, Inc.

Recruiting

PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury

Acute Spinal Cord Injury

India
KU Leuven
Vrije Universiteit Brussel; AZ Herentals

Recruiting

Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease (INTeRAcT)

Stroke | Chronic Disease | Spinal Cord Injuries

Belgium
University Hospital, Ghent
University Ghent

Recruiting

The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System

Stroke | Traumatic Brain Injury | Spinal Cord Injuries

Belgium
Hasselt University
Jessa Hospital; Sint-Trudo Hospital; Sint-Franciscus Ziekenhuis

Suspended

Extreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF) (XLIF)

Atrophy | Muscle Damage | Degenerative Diseases, Spinal Cord

Belgium
Moens Maarten
Vrije Universiteit Brussel

Recruiting

Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation. (PIANISSIMO)

Spinal Cord Stimulation | Persistent Spinal Pain Syndrome Type 2

Belgium
Dr. Stéphanie Delstanche
Queen Fabiola Children's University Hospital; Erasme University Hospital; SYSNAV and other collaborators

Active, not recruiting

Holter of Movement in Patients With SMA Undergoing Treatment.

Spinal Muscular Atrophy

Belgium
Benvenue Medical, Inc.

Completed

The Kiva® System as a Vertebral Augmentation Treatment (KAST)

Spinal Fractures | Back Injuries | Fractures, Compression

United States, Canada, Germany, France, Belgium
Ziekenhuis Oost-Limburg

Unknown

Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome. (HDS)

Back Pain | Spinal Cord Stimulation

Belgium
Centre Hospitalier Régional de la Citadelle
Roche Pharma AG; Biogen; AveXis, Inc.; Association Belge contre les Maladies neuro...

Completed

Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium

Spinal Muscular Atrophy

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Spinal Cord Evoked Potentials as a Tool to Investigate Sensorimotor Processing (SCEPTISM)

Studying Spinal Cord Evoked Potentials in Patients With Intractable Pain.

Belgium
Centre Hospitalier Régional de la Citadelle

Completed

Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3 (EMOTAS)

Spinal Muscular Atrophy Type 3

Belgium
Jean Schoenen

Unknown

tDCS Versus tsDCS for Endometriosis-related Chronic Pelvic Pain Treatment (DCSErCPP)

Endometriosis | Pelvic Pain | Transcranial Direct Current Stimulation | Spinal Cord Stimulation

Belgium
Institut de Myologie, France
Institut Roche

Completed

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy (NatHis-SMA)

Type 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular Atrophy

Belgium, France, Germany
Hoffmann-La Roche

Recruiting

A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy (PUPFISH)

Muscular Atrophy, Spinal

Germany, United States, Belgium
Moens Maarten
KU Leuven; University Ghent; Vrije Universiteit Brussel

Recruiting

Return to Work for Persistent Spinal Pain Syndrome Type II Patients (OPERA)

Failed Back Surgery Syndrome | Spinal Cord Stimulation

Belgium
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults (nOPV2M4a)

Poliomyelitis

Belgium
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Poliomyelitis

Belgium
University of Aarhus
Odense University Hospital; Aarhus University Hospital; CHU de Quebec-Universite... and other collaborators

Completed

Examining Carryover Effect in Patients Treated witH Spinal cOrd Stimulation (ECHO) (ECHO)

Neuralgia | Spinal Cord Stimulation

Denmark, Sweden, Belgium, Canada, Germany, Netherlands
Centre Hospitalier Universitaire de Liege
Centre Hospitalier Régional de la Citadelle; SYSNAV

Recruiting

Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.

Amyotrophic Lateral Sclerosis

Belgium
Novartis Gene Therapies

Completed

Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (STRIVE-EU)

SMA

France, United Kingdom, Italy, Belgium
University Hospital, Ghent

Completed

Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults (IPV-004)

Poliomyelitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

SBRT in the Management of Solid Spinal Metastases

Spinal Metastases | Extradural Tumor

Belgium
Laurent Servais
Centre Hospitalier Régional de la Citadelle; SYSNAV

Recruiting

Holter of Movement in Patients With Amyotrophic Lateral Sclerosis. (ActiALS)

Amyotrophic Lateral Sclerosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Monitoring of Non-invasive Ventilation During Sleep in ALS

Amyotrophic Lateral Sclerosis

Belgium
Brugmann University Hospital

Completed

In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Belgium
Newron Sweden AB
Medtronic; ICON Clinical Research

Completed

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Belgium
Newron Sweden AB
Medtronic; ICON Clinical Research

Terminated

An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Belgium
Novartis Pharmaceuticals

Completed

An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy

Belgium, Germany, Italy, Russian Federation, Poland, Bulgaria, Denmark
Hoffmann-La Roche

Active, not recruiting

A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy (Rainbowfish)

Muscular Atrophy, Spinal

United States, Belgium, Brazil, Russian Federation, Australia, Taiwan, Poland
Newron Sweden AB

Terminated

A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Newron Sweden AB

Terminated

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Hoffmann-La Roche

Completed

A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)

Muscular Atrophy, Spinal

Belgium, United Kingdom, Germany, France, Italy, Netherlands, Poland
Novartis Gene Therapies
PRA Health Sciences

Completed

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2 (SPR1NT)

Spinal Muscular Atrophy

United States, United Kingdom, Australia, Belgium, Canada, Japan
Hoffmann-La Roche

Active, not recruiting

A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy (Jewelfish)

Spinal Muscular Atrophy

Belgium, United States, United Kingdom, France, Poland, Italy, Switzerland, Netherlands, Germany
Hoffmann-La Roche

Recruiting

A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy (MANATEE)

Spinal Muscular Atrophy (SMA)

Belgium, United States, Croatia, Japan, Netherlands, Spain, Canada, Poland, United Kingdom, Portugal, Italy, Australia
Hoffmann-La Roche
Association Française contre les Myopathies (AFM), Paris

Completed

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non Ambulant

Germany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
NMD Pharma A/S

Recruiting

Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy (SYNAPSE-SMA)

Spinal Muscular Atrophy

United States, Spain, Belgium, Denmark, Germany, Netherlands, Italy, Canada
Novartis Pharmaceuticals

Recruiting

Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials (SPECTRUM)

Spinal Muscular Atrophy (SMA)

Spain, Canada, Taiwan, Belgium, Malaysia, China, Japan, Italy, Singapore, United Kingdom, France, Australia, Thailand, Denmark, United States
Hoffmann-La Roche

Completed

Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy (FIREFISH)

Muscular Atrophy, Spinal

Belgium, United States, China, Spain, Japan, France, Brazil, Croatia, Italy, Russian Federation, Saudi Arabia, Serbia, Switzerland, Turkey, Ukraine, Poland
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (SMART)

Spinal Muscular Atrophy

Taiwan, Belgium, Canada, United States, Australia, France, Italy, Portugal, United Kingdom
Hoffmann-La Roche

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants (SUNFISH)

Muscular Atrophy, Spinal

Belgium, United States, China, Spain, Japan, Canada, France, Poland, Brazil, Croatia, Italy, Russian Federation, Turkey, Germany, Serbia, United Kingdom
Biogen

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB115

Healthy Volunteer | Muscular Atrophy, Spinal

Korea, Republic of, Germany, Belgium, Netherlands, France, Italy, Poland, Canada, United Kingdom, Israel
Novartis Pharmaceuticals

Active, not recruiting

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam (STRENGTH)

Spinal Muscular Atrophy

Japan, Belgium, Spain, Canada, United States, Australia, Italy, France, Netherlands
Biogen

Terminated

A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (ENDEAR)

Spinal Muscular Atrophy

Korea, Republic of, United States, Spain, Canada, Germany, Australia, Japan, Sweden, Belgium, France, Italy, Turkey, United Kingdom
Biogen

Completed

A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies (SHINE)

Spinal Muscular Atrophy

United States, Spain, Germany, United Kingdom, Australia, Japan, Canada, Belgium, France, Hong Kong, Italy, Korea, Republic of, Sweden, Turkey
Ipsen

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 (CONTENT2)

Overactive Bladder | Urinary Incontinence

Spain, Israel, Russian Federation, France, Germany, Australia, Belgium, Brazil, United Kingdom, Mexico, Colombia, Chile, Argentina, Lithuania, Peru, Ukraine

Clinical Trials on Metastatic Spinal Cord Compression in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations